Protalix BioTherapeutics, Inc.: Form DEF 14A, filed Sep 1, 2017
Filed with the SEC on Sep 1, 2017 and accepted by EDGAR at Sep 1, 2017, 16:04 ET.
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001144204-17-046387. Last ingested by Listed: Nov 10, 2026, 16:48 ET. Listed shows no prices and gives no investment advice.